Drugs / cH8/1N1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07703514 | Jul 2026 → Apr 2027 expected | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cH8/1N1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07703514 ↗ |
| Route | Intramuscular | “2 monovalent dose intramuscular injections” NCT07703514 ↗ |